全文获取类型
收费全文 | 2036篇 |
免费 | 13篇 |
国内免费 | 3篇 |
专业分类
电工技术 | 7篇 |
综合类 | 2篇 |
化学工业 | 135篇 |
金属工艺 | 8篇 |
机械仪表 | 6篇 |
建筑科学 | 15篇 |
能源动力 | 12篇 |
轻工业 | 18篇 |
水利工程 | 2篇 |
石油天然气 | 2篇 |
无线电 | 29篇 |
一般工业技术 | 127篇 |
冶金工业 | 1626篇 |
自动化技术 | 63篇 |
出版年
2019年 | 7篇 |
2016年 | 7篇 |
2015年 | 10篇 |
2014年 | 12篇 |
2013年 | 39篇 |
2012年 | 10篇 |
2011年 | 21篇 |
2010年 | 14篇 |
2008年 | 29篇 |
2007年 | 16篇 |
2006年 | 14篇 |
2005年 | 11篇 |
2004年 | 12篇 |
2003年 | 16篇 |
2002年 | 15篇 |
2000年 | 7篇 |
1999年 | 49篇 |
1998年 | 452篇 |
1997年 | 247篇 |
1996年 | 180篇 |
1995年 | 104篇 |
1994年 | 71篇 |
1993年 | 87篇 |
1992年 | 17篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 28篇 |
1988年 | 24篇 |
1987年 | 31篇 |
1986年 | 20篇 |
1985年 | 15篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 26篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 32篇 |
1976年 | 122篇 |
1975年 | 18篇 |
1974年 | 10篇 |
1973年 | 9篇 |
1972年 | 11篇 |
1970年 | 7篇 |
1969年 | 6篇 |
1965年 | 8篇 |
1964年 | 10篇 |
1959年 | 9篇 |
1955年 | 8篇 |
排序方式: 共有2052条查询结果,搜索用时 0 毫秒
51.
52.
Cortical spreading depression is a wave of electrical and biochemical changes that spreads across the cerebral cortex. It has been hypothesized to be an important underlying cause of the visual disturbances occurring during the migraine aura, but this is difficult to test in animals or humans. We created a computational model of cortical spreading depression and found that during the wave of biochemical changes the spatial pattern of neural activity broke up into irregular patterns of lines and small patches of highly activated elements. The corresponding visual disturbances that would be produced by these patterns of neural activity resemble the hallucinations reported during the migraine aura, providing strong support for the cortical spreading depression hypothesis of migraine. The model also makes the testable prediction that these hallucinations move at an exponentially increasing speed across the visual field. 相似文献
53.
54.
Glutamate receptors are implicated in the genesis of opioid tolerance and dependence. Factors governing release of amino acids in systems chronically exposed to opiates, however, remain undefined. Using rats, each prepared with a spinal loop dialysis catheter and with a chronic lumbar intrathecal infusion catheter connected to a subcutaneous minipump, the release of amino acids before and during antagonist-precipitated withdrawal in unanesthetized rats was examined. Spinal infusion of morphine (20 nmol/micro l/hr) for 4 d had little effect on resting release of amino acids. In morphine-infused, but not saline-infused, rats naloxone (2 mg/kg, i.p.) evoked an immediate increase in the release of L-glutamate (299 +/- 143%) and taurine (306 +/- 113%) but not other amino acids. The magnitude and time course of the release of these amino acids significantly correlated with behavioral indices of withdrawal intensity. Acute intrathecal pretreatment immediately before naloxone with clonidine (20 microg; alpha2 agonist), MK-801 (3 microg; noncompetitive NMDA antagonist), or aminophosphonopentanoic acid (AP-5; 3 microg; competitive NMDA antagonist) suppressed naloxone-induced increases in spinal L-glutamate and taurine release and behavioral signs of withdrawal in spinal morphine-infused rats. Results point to a correlated increase in spinal L-glutamate release, which contributes to genesis of the opioid withdrawal syndrome. Agents such as clonidine that suppress opioid withdrawal may owe their action to an inhibition of excitatory amino acid release. The effects of MK-801 and AP-5 suggest a glutamate-evoked glutamate release. 相似文献
55.
Despite all advances in the diagnosis and therapy of cardiovascular diseases, the mortality from malignant ventricular tachyarrhythmias is still a major health problem. In addition to established therapeutic strategies in the prevention of sudden cardiac death such as antiarrhythmic drug treatment, catheter ablation or antiarrhythmic drug treatment, cardioverter/defibrillator was introduced to clinical practice in 1980. The number of 50,000 overall implants reflects the current clinical status of the therapy with implantable cardioverter/defibrillators. Significant technical improvements in the defibrillator therapy may contribute to an increase in therapy acceptance. These advances include the introduction of nonthoracotomy lead systems, enhanced defibrillation efficacy, full programmable devices providing tiered electrical therapy, improved diagnostic Holter functions and enhanced arrhythmia detection algorithms. The major present goals of defibrillator therapy are detection and termination of malignant ventricular tachyarrhythmias, prevention of sudden cardiac death, reduction in patient's mortality and improvement in quality of life. The efficacy and safety of defibrillator therapy to prevent sudden arrhythmic death has been proven in several large clinical investigations In patients with this device the annual sudden cardiac death mortality is < 2% even in high-risk patient populations. Compared to sudden cardiac death rate there is a much higher rate of overall cardiac mortality because a defibrillator is not able to prevent nonarrhythmic cardiovascular deaths. There is a clinical impression that cardiovascular mortality is lower in patients treated with an implantable cardioverter/defibrillator compared to patients treated with other therapies. However, there are no results from controlled studies providing scientific evidence that defribillator therapy can decrease overall cardiovascular mortality.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
56.
W Herr U Protzer AW Lohse G Gerken KH Meyer zum Büschenfelde T W?lfel 《Canadian Metallurgical Quarterly》1998,178(1):260-265
57.
YD Yoo JK Park JY Choi KH Lee YK Kang CS Kim SW Shin YH Kim JS Kim 《Canadian Metallurgical Quarterly》1998,4(12):3063-3068
Paclitaxel induces a cell cycle block at G2-M phase by preventing the depolymerization of microtubules and induces p53-independent apoptosis in many cancer cells. We observed that gastric cancer cells treated with paclitaxel have shown a cyclin-dependent kinase (CDK)4 down-regulation. This paclitaxel-induced CDK4 down-regulation resulted in a cell cycle arrest at G1-S phase. To confirm this observation, we prepared stable transfectants that overexpressed CDK4 and analyzed the cell cycle progression. Ectopic expression of CDK4 in SNU cells resulted in a release of paclitaxel-induced G1 arrest. The release of G1 arrest by enforced expression of CDK4 seems to make the cells more sensitive to paclitaxel-induced apoptosis. From this finding, we could then suggest that paclitaxel treatment induces both G1-S and G2-M blocks in the cell cycle progression of gastric cancer cells. 相似文献
58.
LJ Huang FC Chang KH Lee JP Wang CM Teng SC Kuo 《Canadian Metallurgical Quarterly》1998,6(12):2261-2269
2-Amino (6), 2-alkylamino (7-8), 2-methoxy (9), 2-acetamido (10), and 5,8-diacetoxy (11) derivatives of the lead compound 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone (4) were synthesized, together with 6,7-dichloro-5,8dimethoxy-1,4-naphthoquinone (5), a positional isomer of 4. Antiplatelet, antiinflammatory, and antiallergic activities were evaluated, and most compounds were quite potent in all assays. Compounds 5 and 9-11 were especially active; however, 5 was ineffective against neutrophil superoxide formation, and 10 was ineffective against mast cell degranulation. 相似文献
59.
Utilizing data from the Riggs-Yale Project, 45 male and 45 female 18-29-year-old treatment-resistant inpatients undergoing intensive psychoanalytically oriented treatment were studied. Twenty-seven mixed-type anaclitic-introjective inpatients were compared with 29 "pure" anaclitic and 34 "pure" introjective inpatients. At intake, mixed-type inpatients were more clinically impaired (i.e., were more symptomatic, cognitively impaired, and thought disordered) and more vulnerable (i.e., less accurate object representations and more frequently used maladaptive defense mechanisms) in comparison with clearly defined anaclitic and introjective patients. Mixed-type patients, however, improved significantly more in the course of psychoanalytically oriented treatment, in terms of clinical functioning (i.e., symptoms, cognitive functioning) and psychological vulnerability (i.e., utilization of more adaptive defense mechanisms). (PsycINFO Database Record (c) 2010 APA, all rights reserved) 相似文献
60.